Biohit Oyj — Director's Dealing 2017

Apr 10, 2017

Disclosure 351234

Biohit Oyj - Managers' transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, April 10, 2017 at 12:30 pm local time (EEST)

Biohit Oyj has received the following notification.

Person subject to the notification requirement
Name:	Euroclone Spa	Legal Person
Position:	Closely associated person
Person discharging managerial responsibilities in issuer
Name:	Aiolfi, Franco
Position:	Member of the Board/Deputy member
Initial Notification
Reference number:	74370089ATTSNBXJVT29_20170410113223_12
Issuer
Name:	Biohit Oyj
LEI:	74370089ATTSNBXJVT29
Transaction details
Transaction date:	2017-04-05
Venue:	NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction:	Disposal
Instrument:	Share
ISIN:	FI0009005482
Volume:	35
Unit price:	5,67000 Euro
Volume:	79
Unit price:	5,50000 Euro
Volume:	75
Unit price:	5,51000 Euro
Volume:	406
Unit price:	5,50000 Euro
Volume:	379
Unit price:	5,50000 Euro
Volume:	905
Unit price:	5,52000 Euro
Volume:	553
Unit price:	5,53000 Euro
Volume:	2148
Unit price:	5,50000 Euro
Volume:	742
Unit price:	5,50000 Euro
Volume:	270
Unit price:	5,50000 Euro
Volume:	28
Unit price:	5,50000 Euro
Volume:	300
Unit price:	5,50000 Euro
Aggregated transactions
Volume:	5920
Volume weighted average price:	5.50699 Euro

Additional information:

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com